A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
uncontrolled 15 27 15 27 B-chronic_disease
diabetes 28 36 28 36 I-chronic_disease

An 0 2 37 39 O
active 3 9 40 46 O
nonhealing 10 20 47 57 B-chronic_disease
wound 21 26 58 63 I-chronic_disease

An 0 2 64 66 O
allergy 3 10 67 74 O
history 11 18 75 82 O
to 19 21 83 85 O
any 22 25 86 89 O
study 26 31 90 95 O
materials 32 41 96 105 O
including 42 51 106 115 O
local 52 57 116 121 B-allergy_name
anesthetic 58 68 122 132 I-allergy_name
, 68 69 132 133 O
antibiotics 70 81 134 145 B-allergy_name
, 81 82 145 146 O
antimycotics 83 95 147 159 B-allergy_name
, 95 96 159 160 O
dimethyl 97 105 161 169 B-allergy_name
sulfoxide 106 115 170 179 I-allergy_name
, 115 116 179 180 O
human 117 122 181 186 B-allergy_name
albumin 123 130 187 194 I-allergy_name
, 130 131 194 195 O
or 132 134 196 198 O
bovine 135 141 199 205 B-allergy_name
constituents 142 154 206 218 I-allergy_name
, 154 155 218 219 O
or 156 158 220 222 O
hetastarch 159 169 223 233 B-allergy_name

Biopsies 0 8 234 242 B-treatment
taken 9 14 243 248 O
from 15 19 249 253 O
individuals 20 31 254 265 O
with 32 36 266 270 O
infections 37 47 271 281 O
that 48 52 282 286 O
are 53 56 287 290 O
not 57 60 291 294 O
allowed 61 68 295 302 O
to 69 71 303 305 O
enter 72 77 306 311 O
the 78 81 312 315 O
cell 82 86 316 320 B-treatment
therapy 87 94 321 328 I-treatment
core 95 99 329 333 I-treatment

Females 0 7 334 341 B-gender
of 8 10 342 344 O
childbearing 11 23 345 357 O
potential 24 33 358 367 O

Having 0 6 368 374 O
a 7 8 375 376 O
significant 9 20 377 388 O
medical 21 28 389 396 O
history 29 36 397 404 O
that 37 41 405 409 O
the 42 45 410 413 O
investigator 46 58 414 426 O
feels 59 64 427 432 O
is 65 67 433 435 O
not 68 71 436 439 O
safe 72 76 440 444 O
for 77 80 445 448 O
study 81 86 449 454 O
participation 87 100 455 468 O
( 101 102 469 470 O
for 102 105 470 473 O
example 106 113 474 481 O
, 113 114 481 482 O
some 115 119 483 487 O
forms 120 125 488 493 O
of 126 128 494 496 O
autoimmune 129 139 497 507 B-chronic_disease
conditions 140 150 508 518 I-chronic_disease
, 150 151 518 519 O
metastatic 152 162 520 530 B-cancer
cancer 163 169 531 537 I-cancer
, 169 170 537 538 O
infectious 171 181 539 549 B-chronic_disease
diseases 182 190 550 558 I-chronic_disease
such 191 195 559 563 O
as 196 198 564 566 O
HIV 199 202 567 570 B-chronic_disease
, 202 203 570 571 O
HTLV 204 208 572 576 B-chronic_disease
I 209 210 577 578 I-chronic_disease
/ 210 211 578 579 I-chronic_disease
II 211 213 579 581 I-chronic_disease
, 213 214 581 582 O
Hepatitis 215 224 583 592 B-chronic_disease
B 225 226 593 594 I-chronic_disease
, 226 227 594 595 O
Hepatitis 228 237 596 605 B-chronic_disease
C 238 239 606 607 I-chronic_disease
) 239 240 607 608 O

Having 0 6 609 615 O
current 7 14 616 623 O
skin 15 19 624 628 B-chronic_disease
diseases 20 28 629 637 I-chronic_disease
( 29 30 638 639 O
i.e. 30 34 639 643 O
extreme 35 42 644 651 O
and 43 46 652 655 O
active 47 53 656 662 O
eczema 54 60 663 669 B-chronic_disease
, 60 61 669 670 O
psoriasis 62 71 671 680 B-chronic_disease
, 71 72 680 681 O
lichen 73 79 682 688 B-chronic_disease
planus 80 86 689 695 I-chronic_disease
) 86 87 695 696 O
that 88 92 697 701 O
the 93 96 702 705 O
investigator 97 109 706 718 O
feels 110 115 719 724 O
is 116 118 725 727 O
not 119 122 728 731 O
safe 123 127 732 736 O
for 128 131 737 740 O
study 132 137 741 746 O
participation 138 151 747 760 O

Having 0 6 761 767 O
received 7 15 768 776 O
any 16 19 777 780 O
investigational 20 35 781 796 B-treatment
drug 36 40 797 801 I-treatment
within 41 47 802 808 O
30 48 50 809 811 B-upper_bound
days 51 55 812 816 I-upper_bound
prior 56 61 817 822 I-upper_bound
to 62 64 823 825 O
study 65 70 826 831 O
entry 71 76 832 837 O

In 0 2 838 840 O
the 3 6 841 844 O
opinion 7 14 845 852 O
of 15 17 853 855 O
the 18 21 856 859 O
investigator 22 34 860 872 O
, 34 35 872 873 O
must 36 40 874 878 O
be 41 43 879 881 O
medically 44 53 882 891 O
able 54 58 892 896 O
to 59 61 897 899 O
undergo 62 69 900 907 O
the 70 73 908 911 O
administration 74 88 912 926 O
of 89 91 927 929 O
study 92 97 930 935 O
material 98 106 936 944 O
determined 107 117 945 955 O
by 118 120 956 958 O
laboratory 121 131 959 969 O
tests 132 137 970 975 O
obtained 138 146 976 984 O
within 147 153 985 991 O
2 154 155 992 993 B-upper_bound
weeks 156 161 994 999 I-upper_bound
before 162 168 1000 1006 O
baseline 169 177 1007 1015 O
for 178 181 1016 1019 O
which 182 187 1020 1025 O
the 188 191 1026 1029 O
investigator 192 204 1030 1042 O
identified 205 215 1043 1053 O
no 216 218 1054 1056 O
clinically 219 229 1057 1067 O
significant 230 241 1068 1079 O
abnormality 242 253 1080 1091 O

Known 0 5 1092 1097 O
bleeding 6 14 1098 1106 B-chronic_disease
disorder 15 23 1107 1115 I-chronic_disease

Known 0 5 1116 1121 O
bovine 6 12 1122 1128 O
or 13 15 1129 1131 O
meat 16 20 1132 1136 B-allergy_name
sensitivity 21 32 1137 1148 O
or 33 35 1149 1151 O
severe 36 42 1152 1158 O
allergies 43 52 1159 1168 O
manifested 53 63 1169 1179 O
by 64 66 1180 1182 O
anaphylaxis 67 78 1183 1194 B-allergy_name
to 79 81 1195 1197 O
any 82 85 1198 1201 O
product 86 93 1202 1209 O

Pregnant 0 8 1210 1218 B-pregnancy

agree 0 5 1219 1224 O
to 6 8 1225 1227 O
not 9 12 1228 1231 B-pregnancy
become 13 19 1232 1238 I-pregnancy
pregnant 20 28 1239 1247 I-pregnancy
or 29 31 1248 1250 O
breastfeed 32 42 1251 1261 O
for 43 46 1262 1265 O
the 47 50 1266 1269 O
period 51 57 1270 1276 O
of 58 60 1277 1279 O
the 61 64 1280 1283 O
study 65 70 1284 1289 O
through 71 78 1290 1297 O
1 79 80 1298 1299 O
month 81 86 1300 1305 O
after 87 92 1306 1311 O
completion 93 103 1312 1322 O
of 104 106 1323 1325 O
the 107 110 1326 1329 O
study 111 116 1330 1335 O

autoimmune 0 10 1336 1346 B-chronic_disease
diseases 11 19 1347 1355 I-chronic_disease
affecting 20 29 1356 1365 O
the 30 33 1366 1369 O
skin 34 38 1370 1374 O
such 39 43 1375 1379 O
as 44 46 1380 1382 O
lupus 47 52 1383 1388 B-chronic_disease

be 0 2 1389 1391 O
willing 3 10 1392 1399 B-contraception_consent
to 11 13 1400 1402 I-contraception_consent
use 14 17 1403 1406 I-contraception_consent
a 18 19 1407 1408 I-contraception_consent
reliable 20 28 1409 1417 I-contraception_consent
form 29 33 1418 1422 I-contraception_consent
of 34 36 1423 1425 I-contraception_consent
contraception 37 50 1426 1439 I-contraception_consent
during 51 57 1440 1446 O
the 58 61 1447 1450 O
study 62 67 1451 1456 O

between 0 7 1457 1464 O
18 8 10 1465 1467 B-lower_bound
years 11 16 1468 1473 I-lower_bound
and 17 20 1474 1477 O
65 21 23 1478 1480 B-upper_bound
years 24 29 1481 1486 I-upper_bound
of 30 32 1487 1489 O
age 33 36 1490 1493 B-age

female 0 6 1494 1500 B-gender

have 0 4 1501 1505 O
a 5 6 1506 1507 O
negative 7 15 1508 1516 B-pregnancy
pregnancy 16 25 1517 1526 I-pregnancy
test 26 30 1527 1531 O
at 31 33 1532 1534 O
screening 34 43 1535 1544 O

male 0 4 1545 1549 B-gender

subjects 0 8 1550 1558 O
allergic 9 17 1559 1567 O
to 18 20 1568 1570 O
penicillin 21 31 1571 1581 B-allergy_name
, 31 32 1581 1582 O
streptomycin 33 45 1583 1595 B-allergy_name
, 45 46 1595 1596 O
amphotericin 47 59 1597 1609 B-allergy_name

those 0 5 1610 1615 O
who 6 9 1616 1619 O
are 10 13 1620 1623 O
on 14 16 1624 1626 O
chronic 17 24 1627 1634 B-treatment
immunosuppressive 25 42 1635 1652 I-treatment
therapies 43 52 1653 1662 I-treatment
such 53 57 1663 1667 O
as 58 60 1668 1670 O
oral 61 65 1671 1675 B-treatment
steroids 66 74 1676 1684 I-treatment
, 74 75 1684 1685 O
but 76 79 1686 1689 O
also 80 84 1690 1694 O
those 85 90 1695 1700 O
on 91 93 1701 1703 O
chronic 94 101 1704 1711 B-treatment
topical 102 109 1712 1719 I-treatment
steroids 110 118 1720 1728 I-treatment
in 119 121 1729 1731 O
the 122 125 1732 1735 O
area 126 130 1736 1740 O
of 131 133 1741 1743 O
investigation 134 147 1744 1757 O

trying 0 6 1758 1764 B-pregnancy
to 7 9 1765 1767 I-pregnancy
become 10 16 1768 1774 I-pregnancy
pregnant 17 25 1775 1783 I-pregnancy

